German medical robotics start-up Reactive Robotics said earlier this month it raised a 7-figure funding amount as it looks to accelerate its platform development and entry into the global market.
The company is reportedly developing a robotic, intelligent therapy device designed to replace manual Very Early Mobilization therapy for use with intensive care patients.
Reactive Robotics said it has developed a prototype, as well as established quality management systems and inked cooperative deals with business partners and suppliers.
Existing investors include MTIP MedTech Innovation Partners AG, High-Tech Gründerfonds, Bayern Kapital and TQ-Group, according to a press release.
Reactive Robotics said it expects to deliver its 1st clinical test product by the 1st quarter of 2018.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!